Skip to main content
. 2015 Jun 5;18(1):19933. doi: 10.7448/IAS.18.1.19933

Table 1.

Maternal characteristics by treatment group

Maternal characteristics N Boosted PI Unboosted PI Other None p a p b
Year of delivery
 1988–1996 107 0 (0) 0 (0) 59 (35.5) 48 (81.4) <0.001 <0.001
 1997–2006 318 18 (12.5) 196 (89.1) 97 (58.4) 7 (11.9)
 2007–2011 164 126 (87.5) 24 (10.9) 10 (6.0) 4 (6.8)
Age (years)
  < 25 72 9 (6.3) 24 (11.0) 22 (13.3) 17 (29.3) <0.001 0.13
 25–35 367 86 (59.7) 137 (62.8) 108 (65.5) 36 (62.1)
  > 35 146 49 (34.0) 57 (26.2) 35 (21.2) 5 (8.6)
CD4 count (cells/mm3)
  < 200 58 16 (11.9) 18 (8.6) 18 (11.2) 6 (11.3) 0.18 0.58
 200–350 101 19 (14.2) 33 (15.8) 40 (24.8) 9 (17.0)
  > 350 398 99 (73.9) 158 (75.6) 103 (64.0) 38 (71.7)
Parity
 Multip with PPTD 7 4 (2.8) 1 (0.45) 1 (0.6) 1 (1.7) <0.001 <0.001
 Multip without PPTD 107 47 (32.9) 35 (15.9) 22 (13.3) 3 (5.1)
 Nulliparous 474 92 (63.3) 184 (83.6) 143 (86.1) 55 (93.2)
Hepatitis C
 Negative 557 135 (93.8) 201 (91.4) 163 (98.2) 58 (98.3) 0.015 0.40
 Positive 32 9 (6.25) 19 (8.64) 3 (1.70) 1 (1.69)
Race
 Black 379 103 (79.2) 130 (62.8) 108 (65.9) 38 (64.4) <0.001 0.006
 Caucasian 140 20 (15.4) 58 (28.0) 42 (25.6) 20 (33.9)
 Other 41 7 (5.40) 19 (9.2) 14 (8.54) 1 (1.70)
a

Chi-square test across all categories

b

Chi-square test comparing only boosted to unbooted PIs.